The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Finomel Emulsion for Infusion



Baxter Holding B.V.PA2299/044/002

Main Information

Trade NameFinomel Emulsion for Infusion
Active SubstancesAlanine
Arginine
Glycine
Histidine
Isoleucine
Leucine
Lysine hydrochloride
Methionine
Phenylalanine
Proline
Serine
Threonine
Tryptophan
Tyrosine
Valine
Sodium acetate trihydrate
Potassium chloride
Calcium chloride dihydrate
Magnesium sulphate heptahydrate
Sodium Glycerophosphate Hydrate
Zinc sulphate heptahydrate
Glucose monohydrate
Soya Bean Oil, Refined Ph.Eur
Olive oil, refined
Medium chain triglycerides saturated
Fish oil, rich in omega-3 acids
Dosage FormEmulsion for infusion
Licence HolderBaxter Holding B.V.
Licence NumberPA2299/044/002

Group Information

ATC CodeB05BA Solutions for parenteral nutrition
B05BA01 amino acids

Status

License statusAuthorised
Licence Issued19/07/2019
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back